Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 333 followers

Latest posts

Last updated about 3 hours ago

Human medicines European public assessment report (EPAR): Voranigo, vorasidenib, Date of authorisation: 17/09/2025, Revision: 2, Status: Authorised

about 3 hours ago

Human medicines European public assessment report (EPAR): Voranigo, vorasidenib, Date of authorisation...

Human medicines European public assessment report (EPAR): Ultomiris, ravulizumab, Date of authorisation: 02/07/2019, Revision: 21, Status: Authorised

about 3 hours ago

Human medicines European public assessment report (EPAR): Ultomiris, ravulizumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab, Date of authorisation: 22/11/2018, Revision: 24, Status: Authorised

about 4 hours ago

Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Darzalex, daratumumab, Date of authorisation: 20/05/2016, Revision: 30, Status: Authorised

about 4 hours ago

Human medicines European public assessment report (EPAR): Darzalex, daratumumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Tecentriq, atezolizumab, Date of authorisation: 20/09/2017, Revision: 39, Status: Authorised

about 4 hours ago

Human medicines European public assessment report (EPAR): Tecentriq, atezolizumab, Date of authorisation...

Agenda - PDCO agenda of the 21-24 July 2026 meeting

about 4 hours ago

Agenda - PDCO agenda of the 21-24 July 2026 meeting

Human medicines European public assessment report (EPAR): Opdualag, relatlimab,nivolumab, Date of authorisation: 15/09/2022, Revision: 9, Status: Authorised

about 4 hours ago

Human medicines European public assessment report (EPAR): Opdualag, relatlimab,nivolumab, Date of authorisation...

Human medicines European public assessment report (EPAR): LysaKare, arginine,lysine, Date of authorisation: 25/07/2019, Revision: 12, Status: Authorised

about 4 hours ago

Human medicines European public assessment report (EPAR): LysaKare, arginine,lysine, Date of authorisation...

Human medicines European public assessment report (EPAR): Metalyse, tenecteplase, Date of authorisation: 23/02/2001, Revision: 25, Status: Authorised

about 4 hours ago

Human medicines European public assessment report (EPAR): Metalyse, tenecteplase, Date of authorisation...

Human medicines European public assessment report (EPAR): Gobivaz, golimumab, Date of authorisation: 17/11/2025, Revision: 1, Status: Authorised

about 4 hours ago

Human medicines European public assessment report (EPAR): Gobivaz, golimumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Lutathera, lutetium (177Lu) oxodotreotide, Date of authorisation: 26/09/2017, Revision: 17, Status: Authorised

about 4 hours ago

Human medicines European public assessment report (EPAR): Lutathera, lutetium (177Lu) oxodotreotide, Date...

Human medicines European public assessment report (EPAR): Eltrombopag Accord, eltrombopag, Date of authorisation: 28/03/2025, Revision: 6, Status: Authorised

about 5 hours ago

Human medicines European public assessment report (EPAR): Eltrombopag Accord, eltrombopag, Date of...